Kairos Pharma, Ltd. KAPA
KAPA
Kairos Pharma, Ltd. CLGN
CollPlant Biotechnologies Ltd. ENLV
Enlivex Therapeutics Ltd. GDTC
CytoMed Therapeutics Limited PASG
Passage Bio, Inc. LPTX
Leap Therapeutics, Inc. NTRB
Nutriband Inc. CASI
CASI Pharmaceuticals, Inc. ENTO
Entero Therapeutics, Inc. CVKD
Cadrenal Therapeutics, Inc. Common Stock
Kairos Pharma, Ltd. CLGN
CollPlant Biotechnologies Ltd. ENLV
Enlivex Therapeutics Ltd. GDTC
CytoMed Therapeutics Limited PASG
Passage Bio, Inc. LPTX
Leap Therapeutics, Inc. NTRB
Nutriband Inc. CASI
CASI Pharmaceuticals, Inc. ENTO
Entero Therapeutics, Inc. CVKD
Cadrenal Therapeutics, Inc. Common Stock
Performance
| Periode | KAPA | CLGN | ENLV | GDTC | PASG | LPTX | NTRB | CASI | ENTO | CVKD |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 29.00 % | -3.51 % | 27.33 % | -3.43 % | 21.88 % | 55.26 % | 53.08 % | -11.92 % | 328.95 % | -14.66 % |
| YTD | -23.53 % | -38.71 % | -11.69 % | -35.71 % | -51.69 % | -82.21 % | 69.23 % | -42.95 % | 152.06 % | -10.81 % |
| 1Y | -23.03 % | -48.23 % | -35.21 % | 8.17 % | -32.15 % | -76.13 % | 2.39 % | -68.52 % | 191.07 % | -9.93 % |
| 3Y | -55.00 % | -67.61 % | -74.89 % | -43.75 % | -68.17 % | -93.62 % | 89.19 % | -24.11 % | -99.00 % | -77.63 % |
| 5Y | -55.00 % | -67.66 % | -91.70 % | -43.75 % | -97.75 % | -97.38 % | 34.15 % | -89.70 % | -99.99 % | -77.63 % |
| 10Y | -55.00 % | -74.06 % | -99.48 % | -43.75 % | -98.19 % | -99.27 % | 34.15 % | -88.28 % | -100.00 % | -77.63 % |
| Depuis le début | -55.00 % | -74.06 % | -99.67 % | -43.75 % | -98.19 % | -99.27 % | 34.15 % | -99.90 % | -100.00 % | -77.63 % |